Q61955 (KLK8_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Kallikrein-8 Short name=mK8 EC=3.4.21.118 Alternative name(s): Neuropsin Short name=NP Serine protease 19 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 260 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine protease which is capable of degrading a number of proteins such as casein, fibrinogen, kininogen, fibronectin and collagen type IV. Also cleaves L1CAM in response to increased neural activity. Induces neurite outgrowth and fasciculation of cultured hippocampal neurons. Plays a role in the formation and maturation of orphan and small synaptic boutons in the Schaffer-collateral pathway, regulates Schaffer-collateral long-term potentiation in the hippocampus and is required for memory acquisition and synaptic plasticity. Involved in skin desquamation and keratinocyte proliferation. Plays a role in the secondary phase of pathogenesis following spinal cord injury. Ref.4 Ref.13 Ref.17 Ref.19 Ref.20 Ref.21 Ref.23 Ref.24 |
| Catalytic activity | Cleavage of amide substrates following the basic amino acids Arg or Lys at the P1 position, with a preference for Arg over Lys. |
| Enzyme regulation | Strongly inhibited by diisopropyl fluorophosphate, leupeptin and (4-amidinophenyl)methanesulfonyl 1-fluoride. Ref.4 |
| Subunit structure | Interacts with SPINK9 By similarity. |
| Subcellular location | Secreted. Cytoplasm. Note: Shows a cytoplasmic distribution in the keratinocytes. Ref.4 Ref.22 |
| Tissue specificity | Expressed in the limbic system of mouse brain and is localized at highest concentration in pyramidal neurons of the hippocampal CA1-3 subfields. Also detected in spinal cord gray matter and in keratinized stratified epithelia of epidermis, hair, tongue, palate, nasal cavity, pharynges, esophagus and forestomach. In skin and mucus membranes, expressed in stratum spinosum and stratum granulosum. Expressed during estrus in vaginal epithelial cells but not stromal cells. Within the vaginal epithelium, expressed in prickle cells, granular cells and parakeratotic cells but not in basal cells. Not expressed in uterus. Expressed in the keratinocytes. Ref.1 Ref.5 Ref.6 Ref.9 Ref.10 Ref.22 Ref.24 |
| Developmental stage | Expression is detected in the brain from embryonic day 12 and continues into adulthood. Ref.6 |
| Induction | By chemical/incision-induced brain injury which leads to increased expression in axon fiber bundles of the peri-lesioned region, by electrically-induced seizure (kindling) in brain, by UV irradiation in skin and by incisional and chemically-induced skin wounding which causes epidermal proliferation and hyperkeratosis. Induced by chemically-induced oxidative stress which leads to increased expression in the hippocampal pyramidal neurons 2 hours after treatment. Levels then decrease, drop to 60% of pretreated control levels at day 7 when avoidance learning is impaired and return to control levels at day 30. Also induced by spinal crush injury which leads to increased expression in spinal cord white matter adjacent to the lesion. Expression increases between days 1-14 post-injury with a peak at day 4. Ref.4 Ref.7 Ref.8 Ref.9 Ref.11 Ref.12 Ref.16 Ref.18 Ref.24 |
| Disruption phenotype | Mice display marked abnormalities of synapses and neurons in the CA1 subfield of the hippocampus with enlarged and elongated pyramidal cell soma and reduced asymmetrical synapse numbers. Mutants also display impaired spatial memory acquisition, increased hippocampal susceptibility to hyperexcitability in response to repetitive afferent stimulation and prolonged recovery of UV-irradiated skin. Following spinal cord injury, mutants display reduced demyelination, oligodendrocyte death and axonal degeneration, and inproved hind limb recovery, suggesting that attenuation of neuropsin activity may be beneficial in the treatment of spinal cord injury. Blocking of Klk8 activity by intraventricular injection with monoclonal antibodies reduces or eliminates epileptic seizures in kindled mice. Ref.14 Ref.15 Ref.18 Ref.20 Ref.21 Ref.23 Ref.24 |
| Sequence similarities | Belongs to the peptidase S1 family. Kallikrein subfamily. Contains 1 peptidase S1 domain. |
| Biophysicochemical properties | Kinetic parameters: KM=300 µM for Boc-Val-Pro-Arg-MCA Ref.4 KM=540 µM for Boc-Phe-Ser-Arg-MCA KM=280 µM for D-Val-Leu-Arg-MCA |
| Mass spectrometry | Molecular mass is 26613 Da from positions 29 - 260. Determined by MALDI. Ref.4 Molecular mass is 26229 Da from positions 33 - 260. Determined by MALDI. Ref.4 |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | Potential | |||||||||||||||||||||||||||||||||||||||||||||
| Propeptide | 29 – 32 | 4 | PRO_0000027948 | |||||||||||||||||||||||||||||||||||||||||||||
| Chain | 33 – 260 | 228 | Kallikrein-8 | PRO_0000027949 | ||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 33 – 257 | 225 | Peptidase S1 | |||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 73 | 1 | Charge relay system By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Active site | 120 | 1 | Charge relay system By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Active site | 212 | 1 | Charge relay system By similarity | |||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 110 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 39 ↔ 173 | |||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 58 ↔ 74 | |||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 145 ↔ 246 | |||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 152 ↔ 218 | |||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 184 ↔ 198 | |||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 208 ↔ 233 | |||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 47 – 52 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 55 – 64 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 67 – 70 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 72 – 74 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 80 – 84 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 96 – 98 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 100 – 105 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 122 – 128 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 133 – 136 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 151 – 158 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 160 – 164 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 172 – 178 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 181 – 187 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 189 – 191 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 196 – 200 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 215 – 218 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 221 – 228 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 231 – 233 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 240 – 244 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 245 – 256 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus." Chen Z.-L., Yoshida S., Kato K., Momota Y., Suzuki J., Tanaka T., Ito J., Nishino H., Aimoto S., Kiyama H., Shiosaka S. J. Neurosci. 15:5088-5097(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY. Strain: BALB/c. Tissue: Hippocampus. |
| [2] | "Assignment of the neuropsin gene (Prss19) to mouse chromosome band 7B4 by in situ hybridization." Yoshida S., Hirata A., Inoue N., Shiosaka S. Cytogenet. Cell Genet. 88:97-98(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: Czech II. Tissue: Mammary gland. |
| [4] | "Characterization of recombinant and brain neuropsin, a plasticity-related serine protease." Shimizu C., Yoshida S., Shibata M., Kato K., Momota Y., Matsumoto K., Shiosaka T., Midorikawa R., Kamachi T., Kawabe A., Shiosaka S. J. Biol. Chem. 273:11189-11196(1998) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, MASS SPECTROMETRY. Strain: BALB/c. Tissue: Brain. |
| [5] | "Estrogen-independent expression of neuropsin, a serine protease in the vagina of mice exposed neonatally to diethylstilbestrol." Katsu Y., Takasu E., Iguchi T. Mol. Cell. Endocrinol. 195:99-107(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 85-260, TISSUE SPECIFICITY. Strain: C57BL/6. |
| [6] | "Ontogeny of neuropsin mRNA expression in the mouse brain." Suzuki J., Yoshida S., Chen Z.-L., Momota Y., Kato K., Hirata A., Shiosaka S. Neurosci. Res. 23:345-351(1995) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| [7] | "Kindling induces neuropsin mRNA in the mouse brain." Okabe A., Momota Y., Yoshida S., Hirata A., Ito J., Nishino H., Shiosaka S. Brain Res. 728:116-120(1996) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [8] | "Effects of oxidative stress on the expression of limbic-specific protease neuropsin and avoidance learning in mice." Akita H., Matsuyama T., Iso H., Sugita M., Yoshida S. Brain Res. 769:86-96(1997) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [9] | "Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy." Momota Y., Yoshida S., Ito J., Shibata M., Kato K., Sakurai K., Matsumoto K., Shiosaka S. Eur. J. Neurosci. 10:760-764(1998) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, INDUCTION. |
| [10] | "Expression of neuropsin in the keratinizing epithelial tissue - immunohistochemical analysis of wild-type and nude mice." Inoue N., Kuwae K., Ishida-Yamamoto A., Iizuka H., Shibata M., Yoshida S., Kato K., Shiosaka S. J. Invest. Dermatol. 110:923-931(1998) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [11] | "Effect of 12-O-tetradecanoyl-phorbol ester and incisional wounding on neuropsin mRNA and its protein expression in murine skin." Kitayoshi H., Inoue N., Kuwae K., Chen Z.-L., Sato H., Ohta T., Hosokawa K., Itami S., Yoshikawa K., Yoshida S., Shiosaka S. Arch. Dermatol. Res. 291:333-338(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [12] | "Injury induces neuropsin mRNA in the central nervous system." Tomizawa K., He X.-P., Yamanaka H., Shiosaka S., Yoshida S. Brain Res. 824:308-311(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [13] | "Neuropsin regulates an early phase of Schaffer-collateral long-term potentiation in the murine hippocampus." Komai S., Matsuyama T., Matsumoto K., Kato K., Kobayashi M., Imamura K., Yoshida S., Ugawa S., Shiosaka S. Eur. J. Neurosci. 12:1479-1486(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [14] | "Loss of hippocampal serine protease BSP1/neuropsin predisposes to global seizure activity." Davies B., Kearns I.R., Ure J., Davies C.H., Lathe R. J. Neurosci. 21:6993-7000(2001) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE. |
| [15] | "Abnormalities of synapses and neurons in the hippocampus of neuropsin-deficient mice." Hirata A., Yoshida S., Inoue N., Matsumoto-Miyai K., Ninomiya A., Taniguchi M., Matsuyama T., Kato K., Iizasa H., Kataoka Y., Yoshida N., Shiosaka S. Mol. Cell. Neurosci. 17:600-610(2001) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE. |
| [16] | "Expression of neuropsin in oligodendrocytes after injury to the CNS." He X.-P., Shiosaka S., Yoshida S. Neurosci. Res. 39:455-462(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [17] | "Extracellular serine protease neuropsin (KLK8) modulates neurite outgrowth and fasciculation of mouse hippocampal neurons in culture." Oka T., Akisada M., Okabe A., Sakurai K., Shiosaka S., Kato K. Neurosci. Lett. 321:141-144(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [18] | "Prolonged recovery of ultraviolet B-irradiated skin in neuropsin (KLK8)-deficient mice." Kirihara T., Matsumoto-Miyai K., Nakamura Y., Sadayama T., Yoshida S., Shiosaka S. Br. J. Dermatol. 149:700-706(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION, DISRUPTION PHENOTYPE. |
| [19] | "NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin." Matsumoto-Miyai K., Ninomiya A., Yamasaki H., Tamura H., Nakamura Y., Shiosaka S. J. Neurosci. 23:7727-7736(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [20] | "Role of neuropsin in formation and maturation of Schaffer-collateral L1cam-immunoreactive synaptic boutons." Nakamura Y., Tamura H., Horinouchi K., Shiosaka S. J. Cell Sci. 119:1341-1349(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [21] | "Neuropsin is essential for early processes of memory acquisition and Schaffer collateral long-term potentiation in adult mouse hippocampus in vivo." Tamura H., Ishikawa Y., Hino N., Maeda M., Yoshida S., Kaku S., Shiosaka S. J. Physiol. (Lond.) 570:541-551(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [22] | "SerpinB6 is an inhibitor of kallikrein-8 in keratinocytes." Scott F.L., Sun J., Whisstock J.C., Kato K., Bird P.I. J. Biochem. 142:435-442(2007) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [23] | "Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins." Kishibe M., Bando Y., Terayama R., Namikawa K., Takahashi H., Hashimoto Y., Ishida-Yamamoto A., Jiang Y.-P., Mitrovic B., Perez D., Iizuka H., Yoshida S. J. Biol. Chem. 282:5834-5841(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [24] | "Neuropsin promotes oligodendrocyte death, demyelination and axonal degeneration after spinal cord injury." Terayama R., Bando Y., Murakami K., Kato K., Kishibe M., Yoshida S. Neuroscience 148:175-187(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, INDUCTION, DISRUPTION PHENOTYPE. |
| [25] | "Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis." Kishi T., Kato M., Shimizu T., Kato K., Matsumoto K., Yoshida S., Shiosaka S., Hakoshima T. J. Biol. Chem. 274:4220-4224(1999) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 33-257. Tissue: Hippocampus. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | D30785 mRNA. Translation: BAA06451.1. AB032202 Genomic DNA. Translation: BAA92435.1. BC055895 mRNA. Translation: AAH55895.1. AB074296 mRNA. Translation: BAB92021.1. | ||||||||||||
| IPI | IPI00127511. | ||||||||||||
| PIR | I56559. | ||||||||||||
| RefSeq | NP_032966.1. NM_008940.2. | ||||||||||||
| UniGene | Mm.458023. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q61955. | ||||||||||||
| SMR | Q61955. Positions 33-257. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | 10090.ENSMUSP00000082588. | ||||||||||||
Protein family/group databases | |||||||||||||
| MEROPS | S01.244. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q61955. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q61955. | ||||||||||||
| PRIDE | Q61955. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUST00000085461; ENSMUSP00000082588; ENSMUSG00000064023. | ||||||||||||
| GeneID | 259277. | ||||||||||||
| KEGG | mmu:259277. | ||||||||||||
| UCSC | uc009gns.1. mouse. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 11202. | ||||||||||||
| MGI | MGI:1343327. Klk8. | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5640. | ||||||||||||
| GeneTree | ENSGT00690000101721. | ||||||||||||
| HOGENOM | HOG000251820. | ||||||||||||
| HOVERGEN | HBG013304. | ||||||||||||
| InParanoid | Q61955. | ||||||||||||
| KO | K08650. | ||||||||||||
| OMA | TKLYAEN. | ||||||||||||
| OrthoDB | EOG4XKV7F. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 3.4.21.118. 3474. | ||||||||||||
Gene expression databases | |||||||||||||
| Bgee | Q61955. | ||||||||||||
| CleanEx | MM_KLK8. | ||||||||||||
| Genevestigator | Q61955. | ||||||||||||
| GermOnline | ENSMUSG00000064023. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001254. Peptidase_S1. IPR018114. Peptidase_S1_AS. IPR001314. Peptidase_S1A. IPR009003. Trypsin-like_Pept_dom. [Graphical view] | ||||||||||||
| Pfam | PF00089. Trypsin. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00722. CHYMOTRYPSIN. | ||||||||||||
| SMART | SM00020. Tryp_SPc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF50494. Pept_Ser_Cys. 1 hit. | ||||||||||||
| PROSITE | PS50240. TRYPSIN_DOM. 1 hit. PS00134. TRYPSIN_HIS. 1 hit. PS00135. TRYPSIN_SER. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q61955. | ||||||||||||
| NextBio | 392031. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KLK8_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q61955 Secondary accession number(s): Q8K5D7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
